Autologous intravenous bone marrow mononuclear cell therapy for patients with subacute ischaemic stroke: A pilot study

BACKGROUND & OBJECTIVES: Bone marrow mononuclear cell therapy has emerged as one of the option for the treatment of Stroke. Several preclinical studies have shown that the treatment with mononuclear cell (MNCs) can reduce the infarct size and improve the functional outcome. We evaluated the feas...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Prasad, Kameshwar, Mohanty, Sujata, Bhatia, Rohit, Srivastava, M.V.P., Garg, Ajay, Srivastava, Achal, Goyal, Vinay, Tripathi, Manjari, Kumar, Amit, Bal, Chandrashekar, Vij, Aarti, Mishra, Nalini Kant
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Medknow Publications & Media Pvt Ltd 2012
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3461733/
https://ncbi.nlm.nih.gov/pubmed/22960888
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller